The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 study of the Bruton tyrosine kinase (Btk) inhibitor acalabrutinib alone or with pembrolizumab for metastatic pancreatic cancer (mPC).
 
Michael J. Overman
Consulting or Advisory Role - Merrimack; sirtex Medical
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; MedImmune; Merck; Roche
 
Charles D. Lopez
No Relationships to Disclose
 
Al Bowen Benson
Consulting or Advisory Role - Alchemia; Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech/Roche; Genomic Health; Infinity Pharmaceuticals; Lilly/ImClone; Merck Serono; Merck/Schering Plough; National Cancer Institute; Pharmacyclics; Precision Therapeutics; Sanofi; Spectrum Pharmaceuticals; Taiho Pharmaceutical; Vicus Therapeutics
Research Funding - advanced accelerator applications; Alchemia; Amgen; Astellas Pharma; AVEO; Bayer/Onyx; EMD Serono (Inst); Genentech (I); Gilead Sciences; Infinity Pharmaceuticals; Merck Serono (Inst); Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Bayer; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals
 
Sattva Swarup Neelapu
Consulting or Advisory Role - Merck
Research Funding - Acerta Pharma; Merck
 
Niharika B. Mettu
No Relationships to Disclose
 
Andrew H. Ko
Consulting or Advisory Role - ARMO Biosciences; Celgene; Incyte; Merrimack; Oncogenex; Threshold Pharmaceuticals
Research Funding - Aduro Biotech (Inst); Celgene (Inst); ImClone Systems (Inst); Infinity Pharmaceuticals (Inst); PharmaEngine (Inst); PRISM BioLab (Inst); Seagen (Inst)
 
Vincent M. Chung
Consulting or Advisory Role - Celgene; Perthera
Speakers' Bureau - Celgene
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Celgene
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; Baxalta; Takeda
 
James Andrew Reeves
Stock and Other Ownership Interests - Celgene
Speakers' Bureau - Celgene
Research Funding - Sarah Cannon Research Institute
 
Johanna C. Bendell
No Relationships to Disclose
 
Philip Agop Philip
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Merrimack; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Halozyme; Ipsen; Merrimack; novartis
Speakers' Bureau - amgen; Bayer; Celgene; roche; sanofi
Research Funding - Bayer (Inst); Genentech (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst)
 
Rita Dalal
Employment - Lilly; Merck
Stock and Other Ownership Interests - Lilly
 
Maria Fardis
Employment - Acerta Pharma; Pharmacyclics
Leadership - Acerta Pharma; Pharmacyclics
Stock and Other Ownership Interests - Acerta Pharma; Pharmacyclics
Research Funding - Acerta Pharma; Pharmacyclics
Patents, Royalties, Other Intellectual Property - Pharmacyclics
 
Joy Greer
Employment - Acerta Pharma
 
Xiaolin Wang
Employment - Acerta Pharma
 
Sandeep Inamdar
Employment - Acerta Pharma
 
Brian Joseph Lannutti
No Relationships to Disclose
 
Wayne Rothbaum
Employment - Acerta Pharma
Leadership - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Patents, Royalties, Other Intellectual Property - Acerta Pharma
Travel, Accommodations, Expenses - Acerta Pharma
 
Raquel Izumi
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Consulting or Advisory Role - Trigemina
Patents, Royalties, Other Intellectual Property - Patents pending for Acerta Pharma
 
Milind M. Javle
No Relationships to Disclose